CD63 and hepatocellular carcinoma: The results mentioned above suggested that CD63 may suppress HCC cell proliferation and migration possibly by inhibiting the expression of cytokines IL‐6 and IL27, which in turn inactivate inflammation‐related oncogenic signalling pathways.